BioMerieux/ FR0013280286 /
4/24/2024 5:29:59 PM | Chg. -0.90 | Volume | Bid5:30:00 PM | Ask5:30:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
100.90EUR | -0.88% | 31,359 Turnover: 1.71 mill. |
-Bid Size: - | -Ask Size: - | 11.92 bill.EUR | 0.84% | 33.23 |
GlobeNewswire
4/18
deepull appoints Kimberle Chapin, MD, as Chief Medical Officer and Wade Stevenson as Chief Marketing...
GlobeNewswire
12/4/2023
Oxford Biomedica signs agreement to acquire ABL Europe from Institut Mérieux, consolidating position...
GlobeNewswire
9/20/2023
Oxford Biomedica and Institut Mérieux enter into exclusive negotiations with respect to the proposed...
GlobeNewswire
10/4/2021
Quotient Limited Announces Appointment of New Chief Scientific & Medical Officer
GlobeNewswire
9/16/2021
Inventiva announces major recruitments to accelerate the development of lanifibranor in NASH
GlobeNewswire
6/1/2021
Quotient Limited Provides Fourth Quarter and Full Year Fiscal 2021 Results and provides Business Upd...
GlobeNewswire
3/10/2021
Oncorus Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights
GlobeNewswire
1/4/2021
Oncorus to Build GMP Viral Immunotherapy Clinical Manufacturing Facility in Andover, Mass.
GlobeNewswire
9/17/2020
Victory Square Provides Corporate Update on the Strong Performance of Portfolio Companies
GlobeNewswire
5/4/2020
Alexis RIDEAU appointed Chief Executive Officer of DEINOVE with the ambition to strengthen the Comp...
GlobeNewswire
4/1/2020
Cancer Biomarker Sales to Reach US$ 27 Bn by 2025; Government Funding Pivotal in Accelerating Market...
GlobeNewswire
3/18/2020
Commercial launch of BIOME Oléoactif®, new cosmetic active co-developed by Deinove and Hallstar Fran...
GlobeNewswire
3/11/2020
DEINOVE passes the 2nd milestone of the AGIR program and receives €1.5m from Bpifrance
GlobeNewswire
2/6/2020
Sharon Laboratories capitalizes on Deinove to sustain its development activities